Intellia Therapeutics Announces First Quarter 2022 Financial Results and Highlights Recent Company Progress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ACN
3. NVDA
4. MU
5. GOOGL
6. APGE
7. ABBV
8. DFTX
9. USO
10. IBM

Go back to Intellia Therapeutics Announces First Quarter 2022 Financial Results and Highlights Recent Company Progress

Intellia Therapeutics (NTLA) Misses Q1 EPS by 86c

May 5, 2022 7:43 AM EDT

Intellia Therapeutics (NASDAQ: NTLA) reported Q1 EPS of ($1.96), $0.86 worse than the analyst estimate of ($1.10). Revenue for the quarter came in at $0 versus the consensus estimate of $8.54 million.

For earnings history and earnings-related data on Intellia Therapeutics (NTLA) click here.

... More